Supplemental Table S1 from A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma
Year: 2023
Type: supplementary-materials
Abstract: Clinicopathological characteristics of study populations.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361883774
